AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹60.02 | ₹54.16 | ₹32.90 | ₹45.20 | ₹91.05 |
What is the latest Earnings Per Share (EPS) of AUROBINDO PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹60.02 |
| Mar2024 | ₹54.16 |
| Mar2023 | ₹32.90 |
| Mar2022 | ₹45.20 |
| Mar2021 | ₹91.05 |
How is Earnings Per Share (EPS) of AUROBINDO PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹60.02 | 10.82 | |
| Mar2024 | ₹54.16 | 64.62 | |
| Mar2023 | ₹32.90 | -27.21 | |
| Mar2022 | ₹45.20 | -50.36 | |
| Mar2021 | ₹91.05 | - | |
Compare Earnings Per Share (EPS) of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹84,244.3 Cr | 0.1% | -1.7% | 25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.1% |
-1.7% |
25.4% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses